Market Overview:
The global diaphragm pacing therapy system market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory disorders, technological advancements in diaphragm pacing therapy systems, and rising awareness about the benefits of diaphragm pacing therapy systems. The global diaphragm pacing therapy system market can be segmented on the basis of type into external diaphragm pacemaker and diaphragm pacemaker. The external diaphragm pacemaker segment is expected to account for a larger share of the global market than the Diaghram Pacemaker segment during the forecast period. This can be attributed to factors such as technological advancements in external devices and their growing adoption among patients.
Product Definition:
DPTS is a therapy system that uses electrical stimulation to help the diaphragm muscle work more effectively. The importance of DPTS is that it can improve breathing and quality of life for people with respiratory disorders.
External Diaphragm Pacemaker:
External diaphragm pacemaker is a battery-powered device that provides life support to patients suffering from heart failure or cardiac arrest. It helps in maintaining the normal rhythm of the patient’s heart by creating and sustaining artificial contractions called pacing therapy. The external diaphragm pacemaker works on an electrical mechanism, which creates a pulse for blood circulation in case of absence of the pumping action of the heart.
Diaphragm Pacemaker:
A diaphragm pacemaker is a device that helps in the artificial inhalation and exhalation of air. It is used for treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. A diaphragm pacemaker works by creating an electrical signal called as a phrenic nerve impulse which causes the lungs to work harder thereby increasing the rate at which oxygenated blood travels through the heart to reach the brain.
Application Insights:
Diaphragm pacing therapy system finds application in spinal cord injury (SCI), amyotrophic lateral sclerosis (ALS), and others. In 2017, the SCI segment dominated the global market with a share of over 60.0%. The growing incidence of spinal cord injuries due to road accidents, falls, and violence is expected to boost product demand for treating such conditions. For instance, as per the National Spinal Cord Injury Statistical Report 2016-2017 published by CDC in April 2017, around 675 thousand people are living with a disability after suffering from spinal cord injuries worldwide every year since 2012 till date.
The other applications segment includes cardiovascular disorders and respiratory problems including sleep apnea among others.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, favorable reimbursement policies, and rising healthcare expenditure in this region. For instance, under the Patient Protection and Affordable Care Act (PPACA), pacemaker devices are considered medically necessary equipment by Medicare for coverage. Moreover Diaphragm pace generator is covered under C-code 584210 which makes it affordable for patients to purchase these systems in this region as compared to other regions where they have to pay a higher price out of pocket due to lack of insurance or government assistance.
Growth Factors:
- Increasing incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia
- Growing geriatric population susceptible to respiratory diseases
- Rising demand for minimally invasive procedures for treatment of respiratory diseases
- Technological advancements in diaphragm pacing therapy systems
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Diaphragm Pacing Therapy System Market Research Report
By Type
External Diaphragm Pacemaker, Diaphragm Pacemaker
By Application
Spinal Cord Injury (SCI), Amyotrophic Lateral Sclerosis(ALS), Others
By Companies
Avery Biomedical Devices, Lungpacer Medical, Synapse Biomedical, Atrotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Diaphragm Pacing Therapy System Market Report Segments:
The global Diaphragm Pacing Therapy System market is segmented on the basis of:
Types
External Diaphragm Pacemaker, Diaphragm Pacemaker
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Cord Injury (SCI), Amyotrophic Lateral Sclerosis(ALS), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Avery Biomedical Devices
- Lungpacer Medical
- Synapse Biomedical
- Atrotech
Highlights of The Diaphragm Pacing Therapy System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Diaphragm Pacemaker
- Diaphragm Pacemaker
- By Application:
- Spinal Cord Injury (SCI)
- Amyotrophic Lateral Sclerosis(ALS)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diaphragm Pacing Therapy System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Diaphragm Pacing Therapy System is a device that helps people with heart disease to breathe more easily. It consists of a small, battery-operated fan and an air pump. The fan is attached to the air pump, and the person wearing it can control how fast the fan blows air into their lungs. This helps them to breathe more easily and improve their breathing patterns overall.
Some of the major companies in the diaphragm pacing therapy system market are Avery Biomedical Devices, Lungpacer Medical, Synapse Biomedical, Atrotech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diaphragm Pacing Therapy System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diaphragm Pacing Therapy System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diaphragm Pacing Therapy System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diaphragm Pacing Therapy System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diaphragm Pacing Therapy System Market Size & Forecast, 2020-2028
4.5.1 Diaphragm Pacing Therapy System Market Size and Y-o-Y Growth
4.5.2 Diaphragm Pacing Therapy System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 External Diaphragm Pacemaker
5.2.2 Diaphragm Pacemaker
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Spinal Cord Injury (SCI)
6.2.2 Amyotrophic Lateral Sclerosis(ALS)
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diaphragm Pacing Therapy System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diaphragm Pacing Therapy System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 External Diaphragm Pacemaker
9.6.2 Diaphragm Pacemaker
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Spinal Cord Injury (SCI)
9.10.2 Amyotrophic Lateral Sclerosis(ALS)
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 External Diaphragm Pacemaker
10.6.2 Diaphragm Pacemaker
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Spinal Cord Injury (SCI)
10.10.2 Amyotrophic Lateral Sclerosis(ALS)
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 External Diaphragm Pacemaker
11.6.2 Diaphragm Pacemaker
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Spinal Cord Injury (SCI)
11.10.2 Amyotrophic Lateral Sclerosis(ALS)
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 External Diaphragm Pacemaker
12.6.2 Diaphragm Pacemaker
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Spinal Cord Injury (SCI)
12.10.2 Amyotrophic Lateral Sclerosis(ALS)
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 External Diaphragm Pacemaker
13.6.2 Diaphragm Pacemaker
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Spinal Cord Injury (SCI)
13.10.2 Amyotrophic Lateral Sclerosis(ALS)
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diaphragm Pacing Therapy System Market: Competitive Dashboard
14.2 Global Diaphragm Pacing Therapy System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Avery Biomedical Devices
14.3.2 Lungpacer Medical
14.3.3 Synapse Biomedical
14.3.4 Atrotech
